{
  "docId": "019de075-d132-769f-97bd-4a840dd24899",
  "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
  "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 49,
  "pageCount": 56,
  "prevPage": 48,
  "nextPage": 50,
  "slideType": "peer_benchmark",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 20,
  "notes": "The slide uses a custom bar chart visualization within a table to show market cap ranges (Min, IPO, Today, Max).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/49",
  "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
  "deckJsonHref": "/decks/019de075-d132-769f-97bd-4a840dd24899.json",
  "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-49",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.7,
        "x": 0.28,
        "y": 0.87
      },
      "kind": "callout",
      "text": "Initial financing rounds expected to generate valuable milestones.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "483d640b-f512-41bd-9df8-2db54cd30752",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.18,
        "x": 0.24,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Market cap range visualization (Min, IPO, Today, Max)",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "54593fdd-e6e5-41d9-bb31-41d5abd0a38e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.02,
        "y": 0.87
      },
      "kind": "source-note",
      "text": "NOTE: “Today” market cap as of April 17, 2023 SOURCE: FactSet. Company S-1s.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5241be3b-64b7-48dd-8c51-f239426f3729",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.68,
        "w": 0.96,
        "x": 0.02,
        "y": 0.188
      },
      "kind": "table",
      "text": "Table comparing Prometheus, Morphic, Dice, Ventyx, Pliant, and Spyre across IPO raise, market cap, clinical stage, and program status.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4eec8970-938f-47e9-a06f-354d2bddb75f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.85,
        "x": 0.02,
        "y": 0.04
      },
      "kind": "title",
      "text": "I&I companies with compelling science have maintained value even in market downturns",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cbb02862-1d7c-4a91-86d5-557c7dba46cc",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "4d3ad0d8-1f90-4f7a-80f0-21d702b51bb9",
      "evidence": "Table comparing Prometheus, Morphic, Dice, Ventyx, Pliant, and Spyre across IPO raise, market cap, clinical stage, and program status.",
      "confidence": 0.5
    }
  ],
  "frameworks": [
    {
      "name": "comparison-frame",
      "slug": null,
      "matchId": "f1f8b13a-924e-48e2-812e-ac3a52d0c0e1",
      "evidence": "Compares peer company performance metrics against internal projections.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 56,
      "from": 45,
      "beatId": "a269a747-0743-41c8-a64a-96220e98956c",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "The document outlines the potential impact and next steps for Spyre's pipeline.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}